Establishment Labs (NASDAQ:ESTA) Stock Price Up 6.1%

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shares rose 6.1% during mid-day trading on Monday . The company traded as high as $23.01 and last traded at $23.00. Approximately 52,077 shares traded hands during trading, a decline of 77% from the average daily volume of 227,596 shares. The stock had previously closed at $21.68.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ESTA shares. Stephens restated an “overweight” rating and issued a $89.00 price target on shares of Establishment Labs in a report on Friday, July 21st. JPMorgan Chase & Co. started coverage on Establishment Labs in a report on Thursday, August 31st. They issued an “overweight” rating and a $75.00 price target for the company. B. Riley decreased their price target on Establishment Labs from $95.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, November 9th. Finally, Mizuho decreased their price target on Establishment Labs from $80.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, November 8th. Six research analysts have rated the stock with a buy rating, According to MarketBeat, Establishment Labs has a consensus rating of “Buy” and a consensus target price of $74.67.

Establishment Labs Price Performance

The company has a debt-to-equity ratio of 6.08, a quick ratio of 2.36 and a current ratio of 3.71. The company has a 50 day moving average price of $40.35 and a 200 day moving average price of $56.45.

Hedge Funds Weigh In On Establishment Labs

Several institutional investors and hedge funds have recently made changes to their positions in ESTA. GPS Wealth Strategies Group LLC purchased a new position in shares of Establishment Labs during the 2nd quarter valued at approximately $25,000. BNP Paribas Arbitrage SA raised its position in shares of Establishment Labs by 3,244.4% during the 1st quarter. BNP Paribas Arbitrage SA now owns 602 shares of the company’s stock valued at $41,000 after acquiring an additional 584 shares in the last quarter. Global Retirement Partners LLC acquired a new stake in shares of Establishment Labs during the 3rd quarter valued at approximately $60,000. Lazard Asset Management LLC raised its position in shares of Establishment Labs by 104.5% during the 1st quarter. Lazard Asset Management LLC now owns 963 shares of the company’s stock valued at $64,000 after acquiring an additional 492 shares in the last quarter. Finally, Deutsche Bank AG acquired a new stake in shares of Establishment Labs during the 4th quarter valued at approximately $66,000. 78.56% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.